Results 91 to 100 of about 9,984,497 (332)

Personalized medicine in internal medicine

Clinical Medicine (Russian Journal), 2017
Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized approach to the selection of both the drugs and the selection of the dosing regimen for the purpose of ...
V.F. Marinin, D V Mandich, E V Shih, A B Prokofiev, M. V. Zhuravleva, G.V. Ramenskaya, A S Zhestovskaia, N. B. Lazareva, V V Smirnov, Kukes Vg, O A Goroshko, N.A. Rumyantsev, Yu V Olefir   +12 more
openaire   +3 more sources

Putting Chagas disease on the global health agenda

BMC Medicine, 2023
BMC Medicine
doaj   +1 more source

Psychosomatic medicine, its principles and applications [PDF]

, 1950
Franz Alexander
openalex   +1 more source

Crosstalk between gut microbiota and tumor: tumors could cause gut dysbiosis and metabolic imbalance

Molecular Oncology, EarlyView.
In this research, we analyzed the relationship between gut microbiota and tumor. We discovered that both subcutaneous and metastatic tumors would alter the composition and metabolic function of gut microbiota. Meanwhile, fecal microbiota transplantation also indicated the anti‐tumor role of the gut microbiota, revealing the crosstalk between tumor and ...
Siyuan Zhang, Haimei Wen, Ying Chen, Jingya Ning, Di Hu, Yujiao Dong, Chenyu Yao, Bo Yuan, Shuanying Yang   +8 more
wiley   +1 more source

Journal of Postgraduate Medicine [PDF]

, 1955

openalex   +1 more source

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients: a comprehensive approach

Molecular Oncology, EarlyView.
This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou, Argyro Roumeliotou, Evangelia Pantazaka, Athanasios‐Nasir Shaukat, Athina Christopoulou, Angelos Koutras, Foteinos‐Ioannis Dimitrakopoulos, Vassilis Georgoulias, Anastasia Xagara, Evangelia Chantzara, Fillipos Koinis, Athanasios Kotsakis, Constantinos Stathopoulos, Galatea Kallergi   +13 more
wiley   +1 more source

The accumulation of myeloid‐derived suppressor cells participates in abdominal infection‐induced tumor progression through the PD‐L1/PD‐1 axis

Molecular Oncology, EarlyView.
This study explores how sepsis affects GC progression by creating an immunosuppressive environment. Our findings reveal that sepsis promotes immune dysregulation, enhancing tumor growth and metastasis. Targeting the PD‐1/PD‐L1 pathway with monoclonal antibodies shows potential for restoring immune function and improving outcomes in cancer patients ...
Yiding Wang, Ting Guo, Xiaofang Xing, Xijuan Liu, Xuejun Gan, Yingai Li, Yan Liu, Fei Shan, Zhouqiao Wu, Jiafu Ji, Ziyu Li   +10 more
wiley   +1 more source

March Of Medicine

Journal of Nepal Medical Association, 2003
1. Cutaneous Reactions to Antibiotics. Rees. B. Rees. JAMA, 1964, 189: 685.2. The 'Pill' and Thrombosis. Brit. med. J. 1964,2, 1089.3. Sensitivity to Cow's Milk. Heiner D.C., Wilson J.F.& Lahey M.E.             JAMA 1964. 189; 563. 4. Deficiency State Associated with Isoniazid therapy. Aspinall D.L. Brit. med. J., 1964.2 1177.5 .
openaire   +8 more sources

Potential of Traditional Medicinal Plants for Treating Obesity: A Review [PDF]

2012 International Conference on Nutrition and Food Sciences, IPCBEE vol. 39 (2012) IACSIT Press, Singapore, 2012
Obesity is a global health concern associated with high morbidity and mortality. Therapeutic strategies include synthetic drugs and surgery, which may entail high costs and serious complications. Plant-based medicinal agents offer an alternative approach.
arxiv  

Psychobiotics and the need for better interventional data

BMC Medicine, 2023
BMC Medicine
doaj   +1 more source